marijuana stocks

Supreme Cannabis Third Quarter Earnings Release Scheduled for May 15, 2020

The Supreme Cannabis Company, Inc. (“Supreme Cannabis” or the “Company”) (FIRE.TO) (SPRWF) (53S1.F) today announced that it will be providing its third quarter financial results for the three and nine months ended March 31, 2020 before markets open on May 15, 2020 .

About Supreme Cannabis.

The Supreme Cannabis Company, Inc., (FIRE.TO) (SPRWF) (53S1.F), is a global diversified portfolio of distinct cannabis companies, products and brands. Since 2014, the Company has emerged as one of the world’s fastest-growing, premium plant-driven lifestyle companies. Supreme Cannabis’ portfolio of brands caters to diverse consumer experiences, with brands and products that address recreational, wellness, medicinal and new consumer preferences.

The Company’s brand portfolio includes, 7ACRES, Blissco, Truverra, Sugarleaf and Khalifa Kush Enterprises Canada. Supreme Cannabis’ brands are backed by a focused suite of world-class operating assets that serve key functions in the value chain, including, scaled cultivation, value-add processing, centralized manufacturing and product testing and R&D. Follow the Company on Instagram, Twitter, Facebook, LinkedIn and YouTube.

We simply grow better.

Forward-Looking Information.

Certain statements made in this press release may constitute “forward-looking information” within the meaning of applicable securities laws. Forward-looking information may relate to anticipated events or results and other statements that are not historical facts. The forward-looking information contained in this press release is made as of the date hereof, and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws.

SOURCE The Supreme Cannabis Company, Inc.


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Cara Therapeutics (CARA) & Enteris BioPharma, Inc. Doses First Patient in Phase 1 Trial of Oral KORSUVA™

Enteris BioPharma’s “Feasibility-to-Licensing” Partner, Cara Therapeutics, Doses First Patient in Phase 1…

Tetra Bio-Pharma Inc. (TBPMF) Engages Dalton Pharma for GMP Manufacturing of ARDS-003

Tetra Bio-Pharma Engages Dalton Pharma for GMP Manufacturing of ARDS-003 Tetra Bio-Pharma…

 Village Farms International, Inc. (VFF) Investee DutchCanGrow Provides Update on Production Licensing Lottery for Netherlands

Village Farms International’s Investee DutchCanGrow Provides Update on Production Licensing Lottery for…

Cara Therapeutics, Inc. (CARA) Announces CEO Transition

Cara Therapeutics Announces CEO Transition Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical…